A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

INTRODUCTION: Components of the hedgehog signaling pathway are upregulated in patients with idiopathic pulmonary fibrosis (IPF). Vismodegib, a small-molecule inhibitor of hedgehog signaling, when used in combination with currently available antifibrotic therapy, may be more efficacious than antifibr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pulm Ther
Hlavní autoři: Prasse, Antje, Ramaswamy, Murali, Mohan, Shaun, Pan, Lin, Kenwright, Andrew, Neighbors, Margaret, Belloni, Paula, LaCamera, Peter P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6967289/
https://ncbi.nlm.nih.gov/pubmed/32026407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-019-0096-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky